Anzeige
Mehr »
Samstag, 28.02.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QALD | ISIN: CNE1000040M1 | Ticker-Symbol: 5HZ1
Frankfurt
27.02.26 | 15:25
4,980 Euro
-1,39 % -0,070
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
HANGZHOU TIGERMED CONSULTING CO LTD Chart 1 Jahr
5-Tage-Chart
HANGZHOU TIGERMED CONSULTING CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
5,0505,15013:04

Aktuelle News zur HANGZHOU TIGERMED CONSULTING Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.02.TIGERMED (03347): NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING-
09.02.TIGERMED (03347): FORM OF PROXY FOR THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, MARCH 5, 2026-
09.02.TIGERMED (03347): (1) CHANGE OF REGISTERED ADDRESS OF THE COMPANY AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (2) NOTICE OF 2026 FIRST ...-
02.02.TIGERMED (03347): CHANGE OF REGISTERED ADDRESS OF THE COMPANY AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION-
30.01.TIGERMED Swells 6%+ as 2025 Profit Expected to Grow 105-204% YoY in Positive Profit Alert2
HANGZHOU TIGERMED CONSULTING Aktie jetzt für 0€ handeln
29.01.TIGERMED (03347): ANNUAL RESULTS ESTIMATE FOR 2025-
06.11.25Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30342HANGZHOU, China, Nov. 6, 2025 /PRNewswire/ -- Tigermed has been selected as one of the Top 30 companies on the "2025 Forbes China Go-International Flagship Brands" list, Forbes China...
► Artikel lesen
28.10.25Hangzhou Tigermed Consulting Co Ltd Profit Advances In Nine Months1
28.10.25TIGERMED (03347): 2025 THIRD QUARTERLY REPORT2
16.10.25TIGERMED (03347): DATE OF BOARD MEETING-
14.10.25Goldman Sachs initiates Hangzhou Tigermed stock with Buy rating2
10.10.25TIGERMED (03347): VOLUNTARY ANNOUNCEMENT - DISPOSAL OF THE TARGET GROUP1
29.09.25TIGERMED (03347): ARTICLES OF ASSOCIATION-
29.09.25TIGERMED (03347): POLL VOTING RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 29, 20252
25.09.25TIGERMED (03347): 2025 INTERIM REPORT1
08.09.25TIGERMED (03347): FORM OF PROXY FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, SEPTEMBER 29, 20253
08.09.25TIGERMED (03347): NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING1
08.09.25TIGERMED (03347): 2025 FIRST EGM CIRCULAR-
19.08.25Tigermed Receives MSCI ESG AAA Rating724HANGZHOU, China, Aug. 19, 2025 /PRNewswire/ -- Tigermed is proud to announce that it has been awarded an MSCI Environmental, Social, and Governance (ESG) Rating of AAA, the highest rating...
► Artikel lesen
29.07.25Tigermed Completes Acquisition of Japanese CRO Micron440HANGZHOU, China and TOKYO, July 29, 2025 /PRNewswire/ -- Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical...
► Artikel lesen
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1